Published in

Springer, Investigational New Drugs, 1(34), p. 41-48, 2015

DOI: 10.1007/s10637-015-0304-9

Links

Tools

Export citation

Search in Google Scholar

Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO